Your browser doesn't support javascript.
loading
Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain compared with leuprorelin in Japanese women: a phase 3, randomized, double-blind, noninferiority study.
Harada, Tasuku; Osuga, Yutaka; Suzuki, Yusuke; Fujisawa, Masaki; Fukui, Motoko; Kitawaki, Jo.
Afiliação
  • Harada T; Department of Obstetrics and Gynecology, Tottori University Faculty of Medicine, Yonago, Japan.
  • Osuga Y; Obstetrics and Gynecology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
  • Suzuki Y; Clinical Development Department, ASKA Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Fujisawa M; Clinical Development Department, ASKA Pharmaceutical Co., Ltd., Tokyo, Japan.
  • Fukui M; Medical Affairs Department, ASKA Pharmaceutical Co., Ltd., Tokyo, Japan. Electronic address: fukui-m@aska-pharma.co.jp.
  • Kitawaki J; Department of Obstetrics and Gynecology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
Fertil Steril ; 117(3): 583-592, 2022 03.
Article em En | MEDLINE | ID: mdl-34895700
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Pirimidinonas / Leuprolida / Dor Pélvica / Receptores LHRH / Endometriose / Fármacos para a Fertilidade Feminina Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Pirimidinonas / Leuprolida / Dor Pélvica / Receptores LHRH / Endometriose / Fármacos para a Fertilidade Feminina Idioma: En Ano de publicação: 2022 Tipo de documento: Article